Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106897167 | 10689716 | 7 | F | 20150529 | 20160923 | 20150105 | 20160928 | EXP | US-PFIZER INC-2014363628 | PFIZER | 50.00 | YR | F | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106897167 | 10689716 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 106897167 | 10689716 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, UNK | 21446 | 100 | MG | CAPSULE, HARD | |||||||
| 106897167 | 10689716 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, DAILY | 21446 | 300 | MG | CAPSULE, HARD | |||||||
| 106897167 | 10689716 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 5 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 6 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 7 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 8 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 9 | C | REMERON | MIRTAZAPINE | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 10 | C | ADVIL | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 11 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 12 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 13 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | UNK | 0 | |||||||||||
| 106897167 | 10689716 | 14 | C | MORPHINE | MORPHINE | 1 | Oral | 150 MG, 3X/DAY | 0 | 150 | MG | TABLET | TID | ||||||
| 106897167 | 10689716 | 15 | C | MORPHINE | MORPHINE | 1 | Oral | 30 MG, EVERY 8 HOURS | 0 | 30 | MG | PROLONGED-RELEASE TABLET | TID | ||||||
| 106897167 | 10689716 | 16 | C | MORPHINE | MORPHINE | 1 | Oral | 15 MG, 4X/DAY | 0 | 15 | MG | TABLET | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106897167 | 10689716 | 1 | Fibromyalgia |
| 106897167 | 10689716 | 2 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106897167 | 10689716 | OT |
| 106897167 | 10689716 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106897167 | 10689716 | Abasia | |
| 106897167 | 10689716 | Anger | |
| 106897167 | 10689716 | Anxiety | |
| 106897167 | 10689716 | Arrhythmia | |
| 106897167 | 10689716 | Autoimmune disorder | |
| 106897167 | 10689716 | Blood pressure increased | |
| 106897167 | 10689716 | Drug dependence | |
| 106897167 | 10689716 | Drug ineffective | |
| 106897167 | 10689716 | Heart rate increased | |
| 106897167 | 10689716 | Hypersensitivity | |
| 106897167 | 10689716 | Malaise | |
| 106897167 | 10689716 | Nasopharyngitis | |
| 106897167 | 10689716 | Oxygen saturation decreased | |
| 106897167 | 10689716 | Pain | |
| 106897167 | 10689716 | Panic attack | |
| 106897167 | 10689716 | Post-traumatic stress disorder | |
| 106897167 | 10689716 | Sinusitis | |
| 106897167 | 10689716 | Thyroid neoplasm | |
| 106897167 | 10689716 | Toxicity to various agents | |
| 106897167 | 10689716 | Type 2 diabetes mellitus | |
| 106897167 | 10689716 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106897167 | 10689716 | 1 | 201505 | 0 | ||
| 106897167 | 10689716 | 2 | 201505 | 0 | ||
| 106897167 | 10689716 | 16 | 20141225 | 0 |